Overview

A Study to Evaluate the Interaction Between VicodinĀ® CR and Ethanol in Healthy Male and Female Moderate Alcohol Drinkers

Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
0
Participant gender:
All
Summary
The purpose of this research study is to determine if varying strengths of ethanol affect the drug level and safety profile of VicodinĀ® CR.
Phase:
Phase 1
Accepts Healthy Volunteers?
Accepts Healthy Volunteers
Details
Lead Sponsor:
Abbott
Treatments:
Acetaminophen
Acetaminophen, hydrocodone drug combination
Ethanol
Hydrocodone
Oxycodone
Criteria
Inclusion Criteria:

- Males and females ages 19 to 55

- If female, must be of non-child bearing potential or practicing birth control

- Current alcohol users who are classified as moderate drinkers (defined as 7-21 drinks
per week)

Exclusion Criteria:

- Intolerance towards ethanol

- Is allergic to or has a serious reaction to hydrocodone, other opioids, or
acetaminophen

- Significant GI narrowing or abnormality with a potential to inhibit GI motility or
tablet transport

- History of seizures or convulsions, head injury or other intracranial lesions, or a
pre-existing increase in intracranial pressure

- Has any clinically significant abnormalities on physical examination, ECG, or
laboratory values

- Treatment with any investigational drug within 30 days of administration of study drug
in the Treatment Phase